AU4407797A - Pharmaceutical composition forming a gel - Google Patents
Pharmaceutical composition forming a gelInfo
- Publication number
- AU4407797A AU4407797A AU44077/97A AU4407797A AU4407797A AU 4407797 A AU4407797 A AU 4407797A AU 44077/97 A AU44077/97 A AU 44077/97A AU 4407797 A AU4407797 A AU 4407797A AU 4407797 A AU4407797 A AU 4407797A
- Authority
- AU
- Australia
- Prior art keywords
- gel
- pharmaceutical composition
- composition forming
- forming
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603480A SE9603480L (sv) | 1996-09-23 | 1996-09-23 | Beredningsform för svårlösliga läkemedel |
SE9603480 | 1996-09-23 | ||
PCT/SE1997/001592 WO1998011874A1 (en) | 1996-09-23 | 1997-09-22 | Pharmaceutical composition forming a gel |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4407797A true AU4407797A (en) | 1998-04-14 |
Family
ID=20404002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44077/97A Abandoned AU4407797A (en) | 1996-09-23 | 1997-09-22 | Pharmaceutical composition forming a gel |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2001501194A (sv) |
AU (1) | AU4407797A (sv) |
SE (1) | SE9603480L (sv) |
WO (1) | WO1998011874A1 (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
US6174524B1 (en) | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
FR2777189B1 (fr) * | 1998-04-09 | 2001-04-06 | Chauvin Lab Sa | Composition ophtalmique comprenant un beta-bloquant |
WO2001032181A2 (en) | 1999-11-01 | 2001-05-10 | Alcon Universal Ltd. | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
ES2225573T3 (es) | 2000-07-28 | 2005-03-16 | Alcon, Inc | Composiciones farmaceuticas que contienen tobramicina y goma xantana. |
SE0103369D0 (sv) * | 2001-10-09 | 2001-10-09 | Astrazeneca Ab | Pharmaceutical formulation |
FR2840614B1 (fr) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
FR2855521B1 (fr) | 2003-05-28 | 2005-08-05 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques. |
JP5222462B2 (ja) * | 2003-08-21 | 2013-06-26 | スキャンポ・アーゲー | 眼科用組成物 |
ITPD20040245A1 (it) * | 2004-10-08 | 2005-01-08 | Fidia Advanced Biopolymers Srl | Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali |
FR2876581B1 (fr) * | 2004-10-20 | 2007-05-18 | Interpharm Dev | Composition bioadhesive a liberation programmee |
US20090036404A1 (en) * | 2007-08-02 | 2009-02-05 | Macleod Steven K | Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof |
US20150099751A1 (en) * | 2013-10-07 | 2015-04-09 | King Abdulaziz University | In situ gel loaded with phosphodiesterase type v inhibitors nanoemulsion |
CN106727276A (zh) * | 2015-11-22 | 2017-05-31 | 中国人民解放军第三军医大学 | 原位凝胶制剂及其用途 |
WO2019046844A1 (en) * | 2017-09-02 | 2019-03-07 | Iview Therapeutics, Inc. | PHARMACEUTICAL COMPOSITIONS FORMING IN SITU A GEL AND THEIR USES FOR SINUS DISEASES |
-
1996
- 1996-09-23 SE SE9603480A patent/SE9603480L/sv not_active Application Discontinuation
-
1997
- 1997-09-22 WO PCT/SE1997/001592 patent/WO1998011874A1/en active Application Filing
- 1997-09-22 AU AU44077/97A patent/AU4407797A/en not_active Abandoned
- 1997-09-22 JP JP10514594A patent/JP2001501194A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1998011874A1 (en) | 1998-03-26 |
SE9603480D0 (sv) | 1996-09-23 |
JP2001501194A (ja) | 2001-01-30 |
SE9603480L (sv) | 1998-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6216296A (en) | Pharmaceutical compositions | |
AUPN605795A0 (en) | Analgesic pharmaceutical composition | |
AUPN411195A0 (en) | Medicinal composition | |
AU5136998A (en) | Medicinal composition | |
AU4762797A (en) | Pharmaceutical compositions | |
AU6740298A (en) | Pharmaceutical composition | |
AU2967597A (en) | Pharmaceutical compositions | |
AU7590096A (en) | Drug composition | |
AU3777897A (en) | Pharmaceutical compositions | |
AU5317598A (en) | Novel pharmaceutical compositions | |
AU4407797A (en) | Pharmaceutical composition forming a gel | |
AU5155096A (en) | Pharmaceutical composition | |
AU5274096A (en) | Pharmaceutical compositions | |
AU4330097A (en) | Pharmaceutical compounds | |
AU2531295A (en) | Pharmaceutical composition | |
AU9343098A (en) | Pharmaceutical composition | |
AU3460897A (en) | Medicinal compositions | |
AU4169897A (en) | Pharmaceutical compounds | |
AU1475595A (en) | Pharmaceutical preparation | |
AU4326197A (en) | Pharmaceutical compositions | |
AUPN862596A0 (en) | Pharmaceutical compositions | |
AU4457597A (en) | Pharmaceutical compositions | |
AU1258697A (en) | A pharmaceutical or veterinary composition | |
AU1427895A (en) | Pharmaceutical compositions | |
AU1544195A (en) | Pharmaceutical compositions |